Lymphocyte population | Normal range (cell counts/ml) | At inclusion | 2–3 years | 4–5 years | Long term | ||||
---|---|---|---|---|---|---|---|---|---|
Group A | Group B | Group A | Group B | Group A | Group B | Group A | Group B | ||
Total | 1718–2620 | 1862 ± 764 | 1318 ± 748 | 1348 ± 777 | 1034 ± 584 | 1408 ± 937 | 1135 ± 482 | 1579 ± 616 | 1316 ± 624 |
T cells (CD3+) | 1008–1647 | 1135 ± 485 | 957 ± 629 | 937 ± 569 | 713 ± 477 | 917 ± 561 | 749 ± 440 | 1417 ± 187 | 1143 ± 527 |
CD4 T cells (CD3+CD4+) | 587–1009 | 730 ± 163 | 563 ± 373 | 409 ± 269 | 405 ± 305 | 510 ± 315 | 412 ± 269 | 678 ± 345 | 576 ± 367 |
Naive CD4 T cells (CD4 + CD45RA+) | 161–529 | 195 ± 161 | 145 ± 44 | 197 ± 171 | 152 ± 221 | 187 ± 193 | 158 ± 218 | 372 ± 175 | 290 ± 271 |
CD8 T cells (CD3+CD8+) | 313–644 | 459 ± 182 | 345 ± 228 | 453 ± 259 | 282 ± 171 | 410 ± 245 | 299 ± 153 | 571 ± 39 | 443 ± 185 |
B cells (CD19+) | 121–267 | 70 ± 53* | 119 ± 91* | 300 ± 391 | 137 ± 137 | 175 ± 56 | 208 ± 214 | 188 ± 63 | 197 ± 217 |
NK cells (CD3-CD16+CD56+) | 82–340 | 176 ± 108 | 112 ± 34 | 151 ± 64* | 92 ± 113* | 115 ± 55 | 132 ± 100 | 150 ± 92 | 135 ± 101 |